专利号:WO-2011148392-A1 优先权日:2010-05-28 标题 :Process for the preparation of (2s,4s,5s,7s)-n-(2-carbamyl-2- methylpropyl)-5-amino-4-hydroxy-2,7-diisopropyl-8-[4-methoxy-3-(3- methoxypropoxy)phenyl]-octanamide hemifumarate and its intermediates thereof 发明人:SATYANARAYANA REDDY MANNE; THIRUMALAI RAJAN SRINIVASAN; ESWARAIAH SAJJA; VENKAT REDDY GHOJALA; RAMA SUBBA REDDY KARAMALA; SAHADEVA REDDY MARAMREDDY 权利人:MSN LAB LTD; SATYANARAYANA REDDY MANNE; THIRUMALAI RAJAN SRINIVASAN; ESWARAIAH SAJJA; VENKAT REDDY GHOJALA; RAMA SUBBA REDDY KARAMALA; SAHADEVA REDDY MARAMREDDY 摘要:The present invention relates to a process for the preparation of (2S,4S,5S,7S)-N-(2- Carbamoyl-2-methylpropyl)-5-amino-4-hydroxy-2,7-diisopropyl-8-[4-methoxy-3-(3-methoxy propoxy )phenyl]-octanamide compound of formula- 1 and its pharmaceutically acceptable salts thereof. Further, relates to the processes for the preparation of (R)-4-(2-(halomethyl)-3- methylbutyl)-l-methoxy-2-(3-methoxypropoxy) benzene and (R)-2-(4-methoxy-3-(3-methoxy propoxy) benzyl)-3-methyIbutan-l-ol useful intermediates in the synthesis of compound of formula- 1.
专利号:US-3717556-A 优先权日:1969-06-14 标 题 :PROCESS FOR THE PREPARATION OF beta -HALOGENO-ALKYL-ISOCYANATES 发明人:KAMPE K 权利人:HOECHST AG 摘要:N-halogeno-alkyl- Beta -lactams are rearranged into Beta halogeno-alkyl-isocyanates by contacting them with unsaturated organic compounds, optionally under irradiation. The products are highly reactive and useful for the synthesis of heterocyclic compounds.
专利号:US-5411927-A 优先权日:1992-08-14 标 题 :Process of preparing composite catalysts for production of synthesis gas by oxidative conversion of methane or natural gas 发明人:CHOUDHARY VASANT R; RANE VILAS H; RAJPUT AMARJEET M R 权利人:COUNCIL SCIENT IND RES 摘要:An improved process for the production of synthesis gas (or carbon monoxide and hydrogen) by oxidative conversion of natural gas or methane, which comprises passing continuously a gaseous reactant mixture comprising methane (or natural gas) and oxygen (or air) with or without water vapors over reduced or unreduced composite catalyst, containing non-transition and/or transition metal oxides, represented by the formula Tm.Nn.R.Op, wherein T is selected from Ni, CO, Ir or the like or a mixture thereof, m is T/R mole ratio, N is a transition or non-transition element selected from Ti, Zr, Hf, Zn, Mg, Ca or the like or a mixture thereof, n represents the N/R mole ratio, R is a rare earth element selected from La, Ce, Pr, Ho, Yb or the like, or a mixture thereof, O is oxygen and p is the number of oxygen atoms required to fulfill the valence requirement of the elements in the composite catalyst. Synthesis gas can be produced in high yields and with very high production rate by oxidative conversion of methane or natural gas to CO and H2 or synthesis gas, using the composite catalyst containing non-transition and/or transition metal oxides.
专利号:EP-4217339-A1 优先权日:2020-09-26 标题:A process for the synthesis of anthranilic acid/amide compounds and intermediates thereof
专利号:US-9174924-B2 优先权日:2007-09-17 标 题 :Hydrolysable linkers and cross-linkers for absorbable polymers 发明人:BEZWADA RAO S 权利人:BEZWADA BIOMEDICAL LLC 摘要:The present invention relates to the discovery of new class of linear and multiarmed hydrolysable linkers and cross linkers for use in the synthesis of biodegradable polymers such as, polyesters, polyurethanes, polyamides, polyureas and degradable epoxy amine resin. The linear and multiarmed hydrolysable linkers of the present invention include symmetrical and/or unsymmetrical ether carboxylic acids, amines, amide diols, amine polyols and isocyanates.
专利号:DE-2324441-A1 优先权日:1972-05-15 标题 :METHOD OF SYNTHESIS OF HYDROGENATION CATALYSTS
参考文献:10.1016/j.ejmech.2024.116477 摘要:Jin F, Lin Y, Yuan W, Wu S, Yang M, Ding S, Liu J, Chen Y. Recent advances in c-Met-based dual inhibitors in the treatment of cancers. European Journal of Medicinal Chemistry. 2024 Jun;272():116477. doi: 10.1016/j.ejmech.2024.116477. 参考文献:10.21037/tlcr-24-604 摘要:Li X, Xia Y, Wang C, Huang S, Chu Q. Efficacy of ALK inhibitors in Asian patients with ALK inhibitor-naïve advanced ALK-positive non-small cell lung cancer: a systematic review and network meta-analysis. Transl Lung Cancer Res. 2024 Aug 31;13(8):2015–22. 参考文献:10.1016/j.ejmech.2025.117643 摘要:Zhao X, Yuan L, Gong Z, Li M, Yuan Y, Geng J. New drugs approved by the NMPA in 2024: Synthesis and clinical applications. European Journal of Medicinal Chemistry. 2025 Jul;291():117643. doi: 10.1016/j.ejmech.2025.117643.